The effects of epigalocathechin-3-gallate on the activation of the HER-2 receptor in human head and neck squamous cell carcinoma and breast carcinoma cell lines that show constitutive activation of HER-2 was investigated. This evidence concerns the gene ERBB2 and breast carcinoma.